贝纳利祖马布在严重的乙酸性喘中的现实有效性:32周的评估
International archives of allergy and immunology
|January 6, 2026
概括
在土耳其,本拉利祖马布显著降低了严重埃索诺菲尔喘 (SEA) 患者的埃索诺菲尔细胞数量和恶化. 这项现实世界的研究证实了本拉利祖马的存在.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 贝纳利祖马布是一种抗IL-5受体单克隆抗体,有效地消耗埃索因菲尔,并改善严重的埃索因菲尔喘 (SEA) 的结果.
- 在临床试验之外评估本拉利祖马布的有效性时,现实世界的数据至关重要.
研究的目的:
- 评估本拉利祖马布在土耳其SEA患者中的实际有效性.
- 在国家批准后32周内评估了临床,实验室和功能结果.
主要方法:
- 对接受本拉利祖马布治疗的生物先验成人SEA患者进行了回顾性研究.
- 评估了外周血液中乙氨基酸细胞计数 (PBEC),恶化,喘控制测试 (ACT) 得分,以及基线和32周的螺旋计.
主要成果:
- 观察到PBEC (p < 0.001) 和恶化频率 (p < 0.001) 的显著降低.
- 在ACT得分 (p < 0.001) 和FEV1 (p < 0.001) 中有明显的改善.
- 66.7%的患者被归类为响应者,响应者显示出更高的基线PBEC和肺功能.
结论:
- 贝纳利祖马布在真实世界中的SEA队列中显示出对乙酸性炎症,恶化,症状控制和肺功能的显著改善.
- 结果支持本拉利祖马布作为临床实践中有效和耐受良好的治疗选择.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Antiasthma Drugs: β2-Adrenoceptor Agonists
1.6K
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
1.6K
Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Drugs Used in Lower Respiratory Disorders: Overview
1.0K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.0K


